biotech investing ARCHIMED Life Science Tools & Services Completes Acquisition of Standard BioTools' Microfluidics Business, Now Biomark Scientific
biotech investing Standard BioTools Announces Sale of Mass Cytometry Business and Illumina's Buyout of Contingent Payments to Advance Merger with Treeline Biosciences
biotech investing Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026
biotech investing Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction
biotech investing Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
biotech investing Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry
QIMC Extends DDH-26-05 Drilling to Beyond 1,000 Metres and Launches In-Situ Hydrogen Characterization and Extraction Program at Bennett Hill as Seismic Further Corroborates Two Distinct Hydrogen Systems in Nova Scotia
CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
